Mirae Asset Securities »

Bridgebio Pharma shares owned by Mirae Asset Securities

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Mirae Asset Securities from 13F filings

Historical chart of Mirae Asset Securities investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Mirae Asset Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Mirae Asset Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.9M 104k 76.49

More positions owned by Mirae Asset Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Iren Ordinary Shares (IREN)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Spdr Series Trust State Street Spd (XRT)
Apple (AAPL)
Select Sector Spdr Tr State Street Ind (XLI)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)

View all positions for Mirae Asset Securities

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma